However, a preclinical study comparing injection of a model antigen at different sites in glioma-bearing mice was able to demonstrate that vaccinating far away from the tumor was best to induce optimal CD8 effector function and brain infiltration (84). The gene discussed is CD8A; the disease is neoplasm.